| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 5 | +63.6K | 32.1% | $1.54 | +$97.8K |
| Sells | 4 | -135K | 67.9% | $1.29 | -$174K |
| Net | +1 | -71.1K | -35.9% | -$75.9K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James C. Czirr | 10%+ Owner | $22.7M | -$76.5K | -0.34% | Apr 22, 2024 |
| Richard E. Uihlein | Director, 10%+ Owner | $17.7M | Jan 24, 2024 | ||
| 10X Fund, L.P. | 10%+ Owner | $10.6M | Dec 31, 2022 | ||
| Joel Lewis | President and CEO, Director | $796K | -$46.2K | -5.49% | Dec 23, 2024 |
| Kevin D. Freeman | Director | $116K | +$52K | +80.9% | Dec 24, 2024 |
| Pol F. Boudes | Chief Medical Officer | $71.4K | Jan 24, 2024 | ||
| Kary Eldred | Director | $55.8K | +$15.1K | +37.2% | Dec 24, 2024 |
| Khurram Jamil | Chief Medical Officer | $47.1K | -$12K | -20.4% | Dec 23, 2024 |
| Richard A. Zordani Jr. | Director | $36K | +$19.7K | +121% | Dec 24, 2024 |
| Harold H. Shlevin | Director | $17.6K | +$7.54K | +74.7% | Dec 30, 2024 |
| Jack W. Callicutt | Chief Financial Officer | $6.76K | -$35.5K | -84% | Dec 23, 2024 |
| Gilbert F. Amelio | Director | Jan 24, 2024 | |||
| Gilbert S. Omenn | Director | Jan 24, 2024 | |||
| Benjamin Sr Carson | Director | Jan 24, 2024 | |||
| Marc Rubin | Director | Jan 24, 2024 | |||
| Elissa J. Schwartz | Director | Jan 24, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|